The identification of i) the MMPs/ADAMs and ii) their cleavage sites in CD95L will help us to identify how many s-CD95Ls exist in vivo, and anticipate their stoichiometry to better predict their biological effects on the immune response and the tumor progression. The gene discussed is FASLG; the disease is neoplasm.